iTunes conversion to RSS provided by Feed Flipper: [Web] – [Facebook] – [Donate!]
Podcast redirected by iTunes; please update your Feed Flipper subscription for this feed to the following URL:
http://picklemonkey.net/flipper/convert.php?feed…
Month: November 2012
One-day seminar to explore ophthalmic innovations
The newest ophthalmic innovations with market potential will be the focus of a one-day seminar in Seattle on May 3, 2013 that will connect scientists, venture capitalists, pharmaceutical representatives and others.
Top-line results from Aerie Pharmaceuticals’ AR-13324 Phase 2a study on glaucoma
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive top-line results from its Phase 2a study evaluating AR-13324 for the treatment of glaucoma.
American Academy of Ophthalmology (AAO) 2012 Annual Meeting
Read clinically focused news coverage of key developments from AAO 2012. Medscape Ophthalmology
Inotek announces final data from trabodenoson Phase 2 trial on PAOG or ocular hypertension
Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that final data from a Phase 2 clinical trial of trabodenoson, also known as INO-8875, in patients with …
Aflibercept and ranibizumab comparable in macular degeneration
NEW YORK (Reuters Health) – They’re similarly effective and safe for neovascular age-related macular
degeneration, but intravitreal aflibercept might have an edge over ranibizumab in convenience, researchers
say.
Simple Eye Tests Accurately Identify Schizophrenia
Simple eye tests that identify abnormal eye movements may help clinicians to distinguish between patients with and without schizophrenia. Medscape Medical News
New Vitamin Regimen Could Extend Useful Vision for Up to 20 Years for Sufferers of Retinitis Pigmentosa and Certain Types of Usher Syndrome (Types 2&3)
The Foundation Fighting Blindness has updated its information on the combined treatment regimen of vitamin A palmitate, oily fish (DHA) and lutein, which may slow vision loss in people with retinitis pigmentosa (RP) and Usher syndrome types 2 and 3. Th…
Pfizer communication on risk of serious increase in intraocular pressure with intravitreal injection of excess volume of pegaptanib sodium (Macugen®)
Source: Pfizer
Area: News
Pfizer has issued a communication about a potential for injecting an excess volume of pegaptanib sodium (Macugen®) intravitreally. This risk has been identified in a clinical trial and in clinical practice. Two cases have be…
Instrument-Based Vision Screening Best in 3- to 5-Year-Olds
A new policy statement from the American Academy of Pediatrics published Monday recommends photoscreening and handheld autorefraction as an alternative to visual acuity screening with vision charts in children aged three to five years old. Reuters He…
The Last Medscape 2012 Election Survey
The results of the last in this 5-survey election series that occurred over the past 6 months is consistent with the inconsistency of this exciting presidential race. Medscape Internal Medicine
Mass. Eye and Ear opens new outpatient surgical center in Longwood/Mission Hill area of Boston
Massachusetts Eye and Ear, along with the Beal Companies, LLP, today celebrated the grand opening of its new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston. The location will provide access to Mass. Eye …